Oxford Nanopore has added $59.6m to its latest funding round to bring the round to $98.1m and its overall funding to nearly $692m.

Oxford Nanopore, a UK-based genetic sequencing technology spinout of University of Oxford, today secured an additional £48.4m ($59.6m) from undisclosed new and existing investors to bring its latest round to $98.1m.
The extension follows an initial $38.5m tranche from unnamed backers in January 2020. The consortium includes investors from the US, Europe, the Middle East, Africa and Asia Pacific.
Oxford Nanopore’s existing investors sold $106m worth of shares in a secondary transaction revealed with the first tranche,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?